Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Richards

Showing results (501-510 of 678) with videos related to

Pageof 68
Sort By:
The American Journal of Tropical Medicine and Hygiene|February 6, 1998
Natural polymorphism in the thrombospondin-related adhesive protein of Plasmodium falciparumK J Robson, A Dolo, I R Hackford, et al.
Proceedings. Biological Sciences|November 22, 1996
Ancient DNA suggests a recent expansion of European cattle from a diverse wild progenitor speciesJ F Bailey, M B Richards, V A Macaulay, et al.
American Journal of Preventive Medicine|October 23, 2010
U.S. primary care physicians' lung cancer screening beliefs and recommendationsCarrie N Klabunde, Pamela M Marcus, Gerard A Silvestri, et al.
MMWR. Morbidity and Mortality Weekly Report|April 4, 2015
CDC Grand Rounds: the future of cancer screeningCheryll C Thomas, Thomas B Richards, Marcus Plescia, et al.
Journal of Hospital Medicine|November 30, 2017
Hospitalist Perspective of Interactions with Medicine Subspecialty Consult ServicesTraci N Adams, Joanna Bonsall, Daniel Hunt, et al.
Neuropharmacology|June 25, 2013
Rats are the smart choice: Rationale for a renewed focus on rats in behavioral geneticsClarissa C Parker, Hao Chen, Shelly B Flagel, et al.
Current Biology : CB|November 4, 2008
Complete mitochondrial genome sequence of the Tyrolean IcemanLuca Ermini, Cristina Olivieri, Ermanno Rizzi, et al.
American Heart Journal|August 29, 2018
The impact of incomplete revascularization on early and late outcomes in ST-elevation myocardial infarctionSonya N Burgess, John K French, Tuan L Nguyen, et al.
The Lancet. Rheumatology|January 26, 2024
5-year efficacy and safety of secukinumab in patients with ankylosing spondylitis: end-of-study results from the phase 3 MEASURE 2 trialHelena Marzo-Ortega, Joachim Sieper, Alan J Kivitz, et al.
The New England Journal of Medicine|December 25, 2015
Secukinumab, an Interleukin-17A Inhibitor, in Ankylosing SpondylitisDominique Baeten, Joachim Sieper, Jürgen Braun, et al.
Pageof 68

Showing results (501-510 of 678) with videos related to

Sort By:
Pageof 68
The American Journal of Tropical Medicine and Hygiene|February 6, 1998
Natural polymorphism in the thrombospondin-related adhesive protein of Plasmodium falciparumK J Robson, A Dolo, I R Hackford, et al.
Proceedings. Biological Sciences|November 22, 1996
Ancient DNA suggests a recent expansion of European cattle from a diverse wild progenitor speciesJ F Bailey, M B Richards, V A Macaulay, et al.
American Journal of Preventive Medicine|October 23, 2010
U.S. primary care physicians' lung cancer screening beliefs and recommendationsCarrie N Klabunde, Pamela M Marcus, Gerard A Silvestri, et al.
MMWR. Morbidity and Mortality Weekly Report|April 4, 2015
CDC Grand Rounds: the future of cancer screeningCheryll C Thomas, Thomas B Richards, Marcus Plescia, et al.
Journal of Hospital Medicine|November 30, 2017
Hospitalist Perspective of Interactions with Medicine Subspecialty Consult ServicesTraci N Adams, Joanna Bonsall, Daniel Hunt, et al.
Neuropharmacology|June 25, 2013
Rats are the smart choice: Rationale for a renewed focus on rats in behavioral geneticsClarissa C Parker, Hao Chen, Shelly B Flagel, et al.
Current Biology : CB|November 4, 2008
Complete mitochondrial genome sequence of the Tyrolean IcemanLuca Ermini, Cristina Olivieri, Ermanno Rizzi, et al.
American Heart Journal|August 29, 2018
The impact of incomplete revascularization on early and late outcomes in ST-elevation myocardial infarctionSonya N Burgess, John K French, Tuan L Nguyen, et al.
The Lancet. Rheumatology|January 26, 2024
5-year efficacy and safety of secukinumab in patients with ankylosing spondylitis: end-of-study results from the phase 3 MEASURE 2 trialHelena Marzo-Ortega, Joachim Sieper, Alan J Kivitz, et al.
The New England Journal of Medicine|December 25, 2015
Secukinumab, an Interleukin-17A Inhibitor, in Ankylosing SpondylitisDominique Baeten, Joachim Sieper, Jürgen Braun, et al.
Pageof 68